The board of directors of Targovax ASA (the “Company”) has on 3 November 2016, in accordance with the authorisations granted by the general meeting 13 April 2016, resolved:
- to increase the share capital of up to NOK 114,542.90 by issuance of up to 1,145,429 new shares, each with a nominal value of NOK 0.10 in order to facilitate the exercise of vested employee options; and
- to increase the share capital of up to NOK 6,987.90 by issuance of up to 69,879 new shares, each with a nominal value of NOK 0.10 in order to facilitate the settlement of vested restricted stock units (“RSUs”) granted to the board of directors in the Company.
Depending on the number of vested options exercised and vested RSU’s settled, the share capital may be increased from NOK 4,213,400.10 to up to NOK 4,334,930.90 in total. The share capital increases will be registered in the Register of Business Enterprises (NW: Foretaksregisteret) as soon as practically possible after the exact amount of the capital increases has been determined.
For further information please contact:
Phone: +47 906 56 525
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.